AUPO900297A0 - A method of modulating cellular activity - Google Patents

A method of modulating cellular activity

Info

Publication number
AUPO900297A0
AUPO900297A0 AUPO9002A AUPO900297A AUPO900297A0 AU PO900297 A0 AUPO900297 A0 AU PO900297A0 AU PO9002 A AUPO9002 A AU PO9002A AU PO900297 A AUPO900297 A AU PO900297A AU PO900297 A0 AUPO900297 A0 AU PO900297A0
Authority
AU
Australia
Prior art keywords
cellular activity
modulating cellular
modulating
activity
cellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPO9002A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medvet Science Pty Ltd
Original Assignee
Medvet Science Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medvet Science Pty Ltd filed Critical Medvet Science Pty Ltd
Priority to AUPO9002A priority Critical patent/AUPO900297A0/en
Publication of AUPO900297A0 publication Critical patent/AUPO900297A0/en
Priority to AU89658/98A priority patent/AU757358B2/en
Priority to CA2302838A priority patent/CA2302838C/en
Priority to PCT/AU1998/000730 priority patent/WO1999012533A1/en
Priority to JP2000510431A priority patent/JP4570246B2/ja
Priority to EP98941157A priority patent/EP1011654A4/de
Priority to US09/977,217 priority patent/US6649362B2/en
Priority to US10/679,485 priority patent/US7172879B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
AUPO9002A 1997-09-08 1997-09-08 A method of modulating cellular activity Abandoned AUPO900297A0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
AUPO9002A AUPO900297A0 (en) 1997-09-08 1997-09-08 A method of modulating cellular activity
AU89658/98A AU757358B2 (en) 1997-09-08 1998-09-08 A method of modulating cellular activity
CA2302838A CA2302838C (en) 1997-09-08 1998-09-08 Modulation of the sphingosine kinase signalling pathway
PCT/AU1998/000730 WO1999012533A1 (en) 1997-09-08 1998-09-08 A method of modulating cellular activity
JP2000510431A JP4570246B2 (ja) 1997-09-08 1998-09-08 細胞活性を調節する方法
EP98941157A EP1011654A4 (de) 1997-09-08 1998-09-08 Methoden zur modulierung der zell aktivität
US09/977,217 US6649362B2 (en) 1997-09-08 2001-10-16 Screening method for an agent having an effect on a sphingosine kinase signaling pathway
US10/679,485 US7172879B2 (en) 1997-09-08 2003-10-07 Detection of sphingosine kinase activity and sphingosine kinase agonist or antagonist activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO9002A AUPO900297A0 (en) 1997-09-08 1997-09-08 A method of modulating cellular activity

Publications (1)

Publication Number Publication Date
AUPO900297A0 true AUPO900297A0 (en) 1997-10-02

Family

ID=3803288

Family Applications (2)

Application Number Title Priority Date Filing Date
AUPO9002A Abandoned AUPO900297A0 (en) 1997-09-08 1997-09-08 A method of modulating cellular activity
AU89658/98A Expired AU757358B2 (en) 1997-09-08 1998-09-08 A method of modulating cellular activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU89658/98A Expired AU757358B2 (en) 1997-09-08 1998-09-08 A method of modulating cellular activity

Country Status (5)

Country Link
EP (1) EP1011654A4 (de)
JP (1) JP4570246B2 (de)
AU (2) AUPO900297A0 (de)
CA (1) CA2302838C (de)
WO (1) WO1999012533A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100798375B1 (ko) * 1999-05-13 2008-01-28 존슨 앤드 존슨 파머슈티컬 리서치 앤드 디벨로프먼트 엘엘씨 스핀고신 키나제 효소
AUPQ744700A0 (en) * 2000-05-11 2000-06-01 Medvet Science Pty. Ltd. A method of treatment and agents useful for same
EP1195604A1 (de) * 2000-09-29 2002-04-10 Warner-Lambert Company Verfahren und Zusammensetzungen zum Screenen von Modulatoren von Lipidkinasen
US6610534B2 (en) * 2000-10-05 2003-08-26 Novartis Ag Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases
EP1404364A4 (de) * 2001-06-07 2005-09-28 Medvet Science Pty Ltd Sphingosin-kinase interagiert mit traf2 und moduliert die durch den tumornekrosefaktor induzierte zellaktivität
CA2480661A1 (en) * 2002-03-28 2003-10-09 Medvet Science Pty. Ltd. A method of modulating cellular activity
JP2006514828A (ja) * 2002-10-14 2006-05-18 メドベット・サイエンス・プロプライエタリー・リミテッド スフィンゴシンキナーゼの機能的レベルを調節することによって上皮細胞活性を調節する方法
EP1481680A1 (de) 2003-05-30 2004-12-01 Aventis Pharma Deutschland GmbH Verwendung von S1P
AU2005253643B2 (en) * 2004-06-15 2011-12-01 Medvet Science Pty. Ltd. Methods of modulating cellular activity involving sphingosine kinase and agents for same, and sphingosine kinase variants
MXPA06014888A (es) * 2004-06-15 2007-03-21 Medvet Science Pty Ltd Metodos para modular actividad celular que involucra esfingosina cinasa y agentes para los mismos, y variantes de esfingosina cinasa.
JP2008528450A (ja) * 2005-01-21 2008-07-31 メドベット サイエンス ピーティーワイ． リミティッド 細胞損傷の治療法
US8747844B2 (en) 2010-07-30 2014-06-10 Saint Louis University Methods of treating pain
US10877045B2 (en) 2015-07-21 2020-12-29 Saint Louis University Compositions and methods for diagnosing and treating endometriosis-related infertility

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766111A (en) * 1985-10-31 1988-08-23 Trustees Of Boston University Lipids with plasmin inhibitory properties
WO1988009345A1 (en) * 1987-05-20 1988-12-01 The Rogosin Institute Reconstituted hdl particles and uses thereof
US5190876A (en) * 1988-12-27 1993-03-02 Emory University Method of modifying cellular differentiation and function and compositions therefor
CA2007507C (en) * 1989-02-03 1998-05-19 Yasuyuki Igarashi Sphingosine and n-methyl-sphingosine as inhibitor of cell growth
US5466716A (en) * 1990-12-31 1995-11-14 The Biomembrane Institute Liposomal trimethylsphingosine
EP0710107A4 (de) * 1993-07-23 1997-05-28 Biomembrane Inst N,n,n-trimethylsphingosin-derivate
AU717243B2 (en) * 1994-12-29 2000-03-23 Regents Of The University Of California, The Compounds for inhibition of ceramide-mediated signal transduction
US5677189A (en) * 1995-06-29 1997-10-14 Oncomembrane, Inc. Method for quantifying sphingosine and for diagnosing platelet activation
JPH09176083A (ja) * 1995-12-28 1997-07-08 Sankyo Co Ltd 新規化合物ｆ−１２５０９ａ

Also Published As

Publication number Publication date
WO1999012533A1 (en) 1999-03-18
CA2302838C (en) 2010-03-16
EP1011654A4 (de) 2004-09-15
JP2001515857A (ja) 2001-09-25
AU757358B2 (en) 2003-02-20
EP1011654A1 (de) 2000-06-28
JP4570246B2 (ja) 2010-10-27
CA2302838A1 (en) 1999-03-18
AU8965898A (en) 1999-03-29

Similar Documents

Publication Publication Date Title
IL114914A0 (en) Modulation of cellular activity
AU9227198A (en) A method for improving skin condition
IL133822A0 (en) Aroylpiperazines for modulating sexual activity
AU4141797A (en) Arrangement of a mobile accommodation of activities
AU2029995A (en) Method of operation of a radio system
AUPO900297A0 (en) A method of modulating cellular activity
AU7831594A (en) A method of promoting cellular function
AU9771498A (en) Arrangement and method relating to radio communication
AUPO863697A0 (en) A computerised method of compiling reports
AU8742398A (en) Method of reducing a schiff base
GB2327175B (en) Method of operating a cellular network
AUPO882497A0 (en) A method of genotyping
AU8817398A (en) Method of drug selection
AU2003204254A1 (en) A Method of Modulating Cellular Activity
AUPP646498A0 (en) A method of modulating ion channel functional activity
AUPO870297A0 (en) Method
AUPO937097A0 (en) Method
AU7908198A (en) A method for pre-fibrillation of lyocell
AU1760499A (en) Catalyst and method for producing polytetrahydrofuran
AU1487199A (en) A communication method and system
AUPP487098A0 (en) A method of modulating cellular adhesion
ZA957223B (en) Modulation of cellular activity
AUPQ075799A0 (en) A method of modulating cellular adhesion
AUPO958197A0 (en) A method of protein engineering
AUPO733797A0 (en) A method of treatment